9G2 — Singapore Institute of Advanced Medicine Holdings Balance Sheet
0.000.00%
Last trade - 00:00- SG$59.11m
- SG$114.48m
- SG$15.71m
Annual balance sheet for Singapore Institute of Advanced Medicine Holdings, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 10.3 | 15.8 | 11.1 | 3.16 | 2.84 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.87 | 4.01 | 1.74 | 1.12 | 1.59 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13.7 | 20.6 | 13.4 | 4.66 | 5.31 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 141 | 138 | 142 | 130 | 116 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 172 | 174 | 160 | 139 | 125 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 31.9 | 50.1 | 52.9 | 12.5 | 17.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 113 | 120 | 115 | 57 | 69.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 59.2 | 54.1 | 44.9 | 81.7 | 55.6 |
| Total Liabilities & Shareholders' Equity | 172 | 174 | 160 | 139 | 125 |
| Total Common Shares Outstanding |